Aurora Cannabis Inc (ACB)
0.6661
-0.02 (-3.10%)
USD |
NASDAQ |
Mar 30, 16:00
0.6985
+0.03 (+4.86%)
After-Hours: 20:00
Aurora Cannabis Revenue (Quarterly): 45.41M for Dec. 31, 2022
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2022 | 45.41M |
| September 30, 2022 | 37.73M |
| June 30, 2022 | 39.30M |
| March 31, 2022 | 39.80M |
| December 31, 2021 | 48.07M |
| September 30, 2021 | 47.72M |
| June 30, 2021 | 44.64M |
| March 31, 2021 | 43.52M |
| December 31, 2020 | 51.93M |
| September 30, 2020 | 50.72M |
| June 30, 2020 | 47.83M |
| March 31, 2020 | 54.85M |
| December 31, 2019 | 41.77M |
| September 30, 2019 | 55.80M |
| June 30, 2019 | 72.14M |
| March 31, 2019 | 48.98M |
| December 31, 2018 | 40.97M |
| September 30, 2018 | 22.70M |
| June 30, 2018 | 14.84M |
| March 31, 2018 | 12.75M |
| December 31, 2017 | 9.199M |
| September 30, 2017 | 6.581M |
| June 30, 2017 | 4.412M |
| March 31, 2017 | 3.908M |
| December 31, 2016 | 2.910M |
| Date | Value |
|---|---|
| September 30, 2016 | 2.355M |
| June 30, 2016 | 0.9465M |
| March 31, 2016 | 0.1597M |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | |
| September 30, 2013 | |
| June 30, 2013 | |
| March 31, 2013 | |
| December 31, 2012 | |
| September 30, 2012 | |
| June 30, 2012 | |
| March 31, 2012 | |
| December 31, 2011 | |
| September 30, 2011 | |
| June 30, 2011 | |
| March 31, 2011 | |
| December 31, 2010 | |
| September 30, 2010 |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
12.75M
Minimum
Mar 2018
72.14M
Maximum
Jun 2019
43.07M
Average
45.03M
Median
Revenue (Quarterly) Benchmarks
| Tilray Brands Inc | 144.14M |
| SNDL Inc | 176.53M |
| InMed Pharmaceuticals Inc | 0.4698M |
| Lucy Scientific Discovery Inc | -- |
| Venus Concept Inc | 24.29M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -48.14M |
| Total Expenses (Quarterly) | 95.89M |
| EPS Diluted (Quarterly) | -0.1472 |
| Enterprise Value | 199.62M |
| Gross Profit Margin (Quarterly) | -26.22% |
| Profit Margin (Quarterly) | -106.0% |
| Earnings Yield | -905.1% |
| Normalized Earnings Yield | -148.18 |